RPE Curvature Can Screen for Early and Intermediate AMD

Area of Science:

• Ophthalmology
• Medical Imaging
• Biomarker Discovery

Background:

• Early diagnosis of age-related macular degeneration (AMD) is crucial for effective clinical management.
• Current diagnostic methods for AMD rely on subjective qualitative assessments, limiting diagnostic accuracy.
• There is a need for objective, quantitative biomarkers to improve AMD diagnosis.

Purpose of the Study:

• To evaluate Retinal Pigment Epithelium (RPE) curvature as an accurate and quantitative measure for diagnosing AMD.
• To determine if RPE curvature can serve as a reliable biomarker for early and intermediate stages of AMD.

Main Methods:

• Retrospective analysis of optical coherence tomography (OCT) B-scans from patients with and without AMD.
• Calculation of RPE curvature using the sinuosity method, comparing RPE length to Bruch's membrane length.
• Determination of diagnostic accuracy using the area under the receiver operator characteristic curve (aROC).

Main Results:

• RPE sinuosity demonstrated acceptable diagnostic accuracy in distinguishing any AMD from non-AMD eyes (aROC = 0.775).
• RPE sinuosity effectively identified intermediate AMD (aROC = 0.871) and differentiated between early and intermediate AMD (aROC = 0.737).
• RPE sinuosity correlated significantly with AMD lesions like reticular pseudodrusen and drusen volume.

Conclusions:

• RPE sinuosity is a simple, robust, and quantitative biomarker for AMD diagnosis.
• This automated method has the potential to enhance the screening and diagnosis of AMD.
• RPE sinuosity offers an objective alternative to current subjective diagnostic measures.